Imatinib Mesylate is an Active Pharmaceutical Ingredient (API) used to manufacture tyrosine kinase inhibitor medication for chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST). Commonly supplied as a white powder with CAS number 220127-57-1.